Humacyte
About:
Humacyte develops products for vascular diseases and replacement of anatomical conduits.
Website: http://humacyte.com
Twitter/X: humacyte
Top Investors: Alexandria Venture Investments, OrbiMed, Fresenius Medical Care, Silicon Valley Bank, Access Industries
Description:
Humacyte develops products for vascular disease and replacement of anatomical conduits. It offers human tissue-based products for regenerative medicine and vascular surgery applications; off-the-shelf extracellular matrix tissue products, which are formed in vitro from banked vascular smooth muscle cells and then decellularized to eliminate the risk of rejection; and vascular grafts.
$748M
$10M to $50M
Morrisville, North Carolina, United States
2004-01-01
Juliana L. Blum, Laura E. Niklason
101-250
2024-11-14
Public
© 2025 bioDAO.ai